ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast - HER2 Support Group Forums

		HER2 Support Group Forums > General Cancer News
ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast

General Cancer News Latest Breast Cancer News from Moreover Technologies

Reply

06-04-2012, 12:01 AM	#1
News Senior Member Join Date: Oct 2007 Posts: 18,958	ImmunoGen reports data from T-DM1 Phase III trial on HER2-positive metastatic breast ImmunoGen, Inc., a biotechnology company with a proprietary Targeted Antibody Payload (TAP) technology, today announced results from the trastuzumab emtansine Phase III EMILIA trial conducted by Roche. More...

Reply

« Previous Thread | Next Thread »

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts BB code is On Smilies are On [IMG] code is On HTML code is Off Forum Rules

All times are GMT -7. The time now is 10:07 PM.

free webpage hit counter